Literature DB >> 11861223

The historical aspects of photocarcinogenesis.

Frederick Urbach1.   

Abstract

The concept of photocarcinogenesis is of fairly recent duration. Although cancer of the breast is described in the ancient Greek medical literature, skin cancer is not mentioned even as late as the 18th Century. This is most likely due to the poor survival of humans, 80% of people did not live past 40 years, and only 6% lived longer than 60 years. The first association of skin cancer (face and lip) with outdoor exposure dates to the middle of the 19th Century. About that time it was shown that it was Ultraviolet Radiation (UVR) that could cause skin and eye inflammation. It was not until the 20th Century that competent epidemiologic studies associated human skin cancer with chronic solar exposure, and it was shown that chemicals could augment the effects of UVR exposure. It has only been in the last quarter of a Century that it was found that UVR could cause immunologic changes that allow multiple skin cancers to develop. Advances in molecular biology have begun to show the cellular and molecular events that lead to UVR induced skin carcinogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 11861223     DOI: 10.2741/A910

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  3 in total

Review 1.  UV "Indices"-What Do They Indicate?

Authors:  Hanns Moshammer; Stana Simic; Daniela Haluza
Journal:  Int J Environ Res Public Health       Date:  2016-10-24       Impact factor: 3.390

2.  Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure.

Authors:  Giovanni Nicoletti; Marco Mario Tresoldi; Alberto Malovini; Borelli Francesco; Angela Faga
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-07

3.  Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice.

Authors:  Fredric J Burns; Toby Rossman; Katherine Vega; Ahmed Uddin; Stefan Vogt; Barry Lai; Richard J Reeder
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.